Ireland vs United States: Immunization, Hib3
Ireland
92.0%
in 2024
United States
92.0%
in 2024
Ireland rank
84th
United States rank
84th
Immunization, Hib3 over time
- Ireland
- United States
How they compare
Ireland currently reports 92.0% against 92.0% in United States, a difference of 0.0%.
The two have swapped places 2 times across 28 shared years of data; in 1997 it was United States ahead.
Ireland ranks 84th and United States ranks 84th of 191 countries.
Across the 4 decades both report, Ireland averaged higher in 2 and United States in 2.
Head to head by decade
| Decade | Ireland | United States | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 82.0% | 93.3% | 11.3% | United States |
| 2000s | 88.6% | 92.2% | 3.6% | United States |
| 2010s | 94.8% | 92.4% | 2.4% | Ireland |
| 2020s | 93.0% | 91.6% | 1.4% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Ireland or United States?
- Ireland, at 92.0% against 92.0% in United States as of 2024.
- What is the difference in immunization, hib3 between Ireland and United States?
- 0.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and United States?
- 28 years are reported by both, from 1997 to 2024.
- How do Ireland and United States rank globally for immunization, hib3?
- Ireland ranks 84th and United States ranks 84th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.